Background: Despite its relatively low incidence of associated diseases, Human T-cell
Leukemia Virus-1 (HTLV-1) infection was reported to carry a significant risk of mortality in …

Limited and contradictory information exists regarding the prognosis of HIV/HTLV-I co-
infection. Our goal was to estimate the effect of HTLV-I infection on mortality in HIV-infected …

The first description of the human T-lymphotropic virus type 1 (HTLV-1) was made in 1980,
followed closely by the discovery of HTLV-2, in 1982. Since then, the main characteristics of …

Introduction Human T-cell leukemia virus type 1 (HTLV-1) carriers may develop adult T-cell
leukemia (ATL), or HTLV-1-associated myelopathy (HAM)/tropical spastic paraparesis …

Objective: To examine the clinical burden and disease spectrum, as well as time trends for
human T-cell leukemia virus type 1 (HTLV-1) and HTLV type 2 (HTLV-2) hospital …

BACKGROUND: HTLV-1/2 diagnosis in high-risk populations from São Paulo, Brazil has
been problematic due a high proportion of seroindeterminate results. OBJECTIVES: To …

Human T-lymphotropic virus (HTLV) infection has a worldwide distribution and currently,
more than 2.5 million individuals have been infected in Brazil. The study aimed to …

The HAM/TSP caused by HTLV-1 infection usually affects patients to disabling states, and
sometimes can lead them to paraplegia presenting symptoms of depression and anxiety …

This study evaluated the performance of single and combined laboratory parameters, B-
lymphocyte percentages (% LB), T/B cell ratio and% CD8+ HLA-DR+/CD8+, to differentiate …

INTRODUCTION: Variations in human T cell lymphotropic virus type 1 (HTLV-1) proviral
load (PVL) in infected individuals over time are not well understood. Objective: To evaluate …